Australia Launches Genomics Australia to Lead Advances in Genomic Medicine

Sidra Medicine Unveils Masterclasses Ahead of PMFG 2024 Summit

FDA Approves Revuforj® as First Menin Inhibitor for Acute Leukemia with KMT2A Translocation

CHMP Recommends Approval of Opdivo® Plus Yervoy® for First-Line Treatment of MSI-H/dMMR Metastatic Colorectal Cancer

ADDF Invests $1.18M to Standardize p-tau217 Blood Tests for Alzheimer’s Diagnosis

GSK Reports Positive Interim Results for DREAMM-7 Trial of Blenrep in Multiple Myeloma

Molbio Diagnostics Invests $30 Million in OptraSCAN to Revolutionize Digital Pathology

BioNTech Acquires Chinese Oncology Firm Biotheus for $950M

The Care and Protection of Children Trust

CPCT Launches Groundbreaking Initiative to Provide Lifelong Free Treatment for Children with Spinal Muscular Atrophy (SMA) in Karnataka

Early Comprehensive Genomic Profiling Improves Cancer Treatment Outcomes, Study Shows

EMA Reverses Decision, Recommends Limited Approval for Eisai and Biogen’s Alzheimer’s Drug Leqembi

Exact Sciences Unveils Advances in Multi-Cancer Early Detection with Cancerguard™ Test

MSD and LaNova Medicines Enter Exclusive Global License Agreement for Novel Cancer Therapy, LM-299

Promising CAR T Cell Therapies from BMS and Cabaletta Bio Show Potential for Durable Remission in Severe Lupus

FDA Grants Accelerated Approval to PTC Therapeutics' KEBILIDI™, the First Gene Therapy for AADC Deficiency in the U.S.

Home
/
update
/
details

Australia Launches Genomics Australia to Lead Advances in Genomic Medicine

NextEdge Admin

18 Nov 2024

2 min 24 sec

Genomics Australia,Genomic medicine,Medical Research

Health Minister Mark Butler has announced the creation of **Genomics Australia**, a national agency under the Department of Health and Aged Care, to lead and coordinate advancements in genomic research and technologies. The initiative has received over $30 million for its first four years, with ongoing funding promised to support its long-term goals.

The new agency aims to position Australia as a global leader in genomic medicine by translating research into clinical applications, improving diagnosis, treatment, and health outcomes. Genomic medicine uses DNA analysis to identify disease risks, prevent illnesses, and deliver tailored healthcare solutions. One of the agency’s first priorities will be enhancing access to personalised care.

Led by a commissioner and supported by expert advisory committees, Genomics Australia will involve researchers, clinicians, industry leaders, consumers, and First Nations representatives. This collaborative model was developed with input from state and territory governments and genomic experts.

“This government is putting Australia at the forefront of research, development, and the use of genomic medicine to help save lives and grow this vital healthcare sector,” Butler said. He highlighted the agency’s role in advancing equitable and accessible genomic treatments.

Since 2015, more than $45 million has been invested in government-funded genomic projects, with $500 million allocated to the Genomics Health Futures Mission under the Medical Research Future Fund since 2018.

“Genomics Australia will provide leadership to drive breakthroughs from the lab to the clinic, delivering better health outcomes for all Australians,” Butler emphasized.